ICL reports Q2 2026 sales higher by 17% to $2.1 billion

ICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.

Original reporting
Published Aug 6, 2026, 4:16 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ICL reports Q2 2026 sales higher by 17% to $2.1 billion — source image
Decision brief

The 30-second read

$ICLBullishMed
01

Why it matters

The combination of higher sales, improved operating income and net income, higher adjusted EBITDA, and stronger free cash flow supports a positive earnings-quality narrative. Reiterated full-year adjusted EBITDA guidance and potash volume expectations provide a concrete anchor for forward estimates, while Elevate’s quantified annualized savings target adds a measurable margin/cash catalyst into 2027-2028.

02

Market read

Traders can update near-term earnings and margin expectations using the Q2 datapoints and the reiterated 2026 EBITDA and potash volume ranges, plus the Elevate savings timeline.

03

What to watch

The article reiterates EBITDA and potash volume ranges but does not quantify segment margins or any guidance sensitivity; traders may need to watch for execution risk in the 2027 organizational realignment and Elevate savings ramp.

Relevance 7/10Novelty 7/10Timing: pre-market today (Q2 results and 2026 guidance reiterated)

Background

ICL is a global specialty minerals company reporting Q2 2026 results and outlining a 2027 organizational realignment plus an enterprise cost-savings program (Elevate).

Company-level read

Ticker impact

$ICLBullishMedium confidence
Context

ICL reported Q2 2026 sales of $2.1B (+17% YoY) and raised operating income and net income, signaling stronger demand and pricing.

Expected impact

Likely positive bias for ICL shares on earnings-quality and margin/cash-flow momentum, with follow-through tied to 2027 cost-savings execution.

Evidence & confidence

The article provides multiple concurrent datapoints (sales, operating income, net income, EBITDA, FCF) plus reiterated full-year guidance and a quantified Elevate savings target, which traders can map to margin and cash-generation expectations.

Market effects

Specialty minerals and fertilizer-linked names may see read-across from ICL’s pricing strength, demand commentary, and cost-savings plan.

Limited direct regional spillover stated, but improved cash generation can influence sentiment toward global specialty-mineral exporters.

Global agriculture and industrial end-market demand signals could modestly affect sentiment across fertilizer and specialty minerals supply chains.

Counterpoint

Strong Q2 growth may partly reflect pricing normalization or timing effects; the market may discount results if cost-savings delivery slips into later quarters.

Key entities

  • ICL

    Reports Q2 2026 sales growth, improved profitability and cash flow, reiterates 2026 adjusted EBITDA guidance, and details Elevate cost savings and a 2027 organizational structure.

Related articles

$ICLMedAI 8/10

ICL Group Ltd (ICL) Q3 2026 Earnings Call Highlights: Industrial Strength and Cost Cuts

ICL Group Ltd reported Q3 2026 earnings, with CEO Elad Aronson and CFO Assaf discussing market outlook, segment performance, and cost management. Key points include stable potash demand, rising phosphate fertilizer demand, and falling sulfur prices. Industrial products sales rose 18% YoY to $347M, with EBITDA up nearly 50%. Potash EBITDA declined 7% YoY due to higher costs. The company expects 2026 EBITDA to be within the $1.5B-$1.7B guidance range, with relief from sulfur costs in 2027.

$ICLMed

ICL Group Ltd Q3 2026 Earnings Call Summary

ICL Group Ltd reported Q3 2026 earnings, highlighting growth from strategic price increases and high-margin products. Key segments showed mixed results: Industrial Products benefited from bromine price increases, Phosphate Solutions saw resilience in specialty products, and Potash margins faced pressure. The company expects 2026 EBITDA of $1.5B-$1.7B and $150M EBITDA improvement in 2027 from cost-cutting.

$ICLMedAI 8/10

ICL Group Q3 Earnings Call Highlights

ICL Group reported Q3 average potash price at $370/ton, up 5% YoY. Phosphate Solutions sales were $589M, EBITDA $118M. Growing Solutions sales were $538M, EBITDA $44M. Sulfur costs rose 220% YoY, impacting Q4. ICL expects $150M EBITDA improvement by 2027. Company to reorganize segments in 2027. Maintained 2026 potash sales forecast of 4.5-4.7M metric tons. Paid $63M dividend in Q3.

$ICLHighAI 8/10

ICL Group (ICL) Q3 2026 Earnings Call Transcript

ICL Group reported Q3 2026 adjusted net income of $126M, up 2%, with EPS at $0.10. Operating cash flow was $256M, and free cash flow was $66M. Industrial Products sales rose 18% YoY, driven by higher bromine prices. Potash sales increased 4% YoY, but EBITDA fell 7% due to cost pressures. Phosphate Solutions sales were $589M with a 20% EBITDA margin, despite higher raw material costs. Growing Solutions sales were $538M with EBITDA of $44M, facing market challenges in Brazil.